Select Bibliography

Filter by any of these (after searching):

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 114 items

A phase 3 study of androgen annihilation in high-risk biochemically relapsed prostate cancer: an Alliance Foundation trial (AFT-19)

Aggarwal, Rahul , Eggener, Scott , Chen, Ronald , Heller, Glenn ... - ASCO - J Clin Oncol - 2018

Abstract - No-Endpoint - Trial-Description-Only - GU - AFT-19

Alliance A031501: Phase III Randomized Adjuvant Study of MK-3475 (Pembrolizumab) in Muscle Invasive and Locally Advanced Urothelial Carcinoma (MIBC) (AMBASSADOR) vs Observation

Apolo, Andrea , Rosenberg, Jonathan , Morris, Michael ... - ASCO GU - J Clin Oncol - 2019

Abstract - No-Endpoint - Trial-Description-Only - GU - A031501

Challenges and Gaps in Clinical Trial Genomic Data Management.

Asad, Sarah , Kananen, Kathryn , Mueller, Kurt R , Symmans, W Fraser ... - - JCO Clin Cancer Inform - 2022

Manuscript - No-Endpoint - Other - PPP - No Study Assigned

Cancer and Leukemia Group B studies of recombinant Interleukin-2 maintenance therapy in acute myeloid leukemia

Baer, M. R. , Kolitz, J. E. , George, S. L. , Caligiuri, M. A. ... - AL - Ann Hematol - 2008

Abstract - No-Endpoint - Comprehensive - Leukemia - CALGB-19808

New strategies to improve drug development in carcinoid tumors (Alliance A021202)

Bergsland, Emily K. , Geyer, Susan M. , Mahoney, Michelle R. ... - NETRF - - 2020

Abstract - No-Endpoint - Trial-Description-Only - GI - A021202

New strategies to improve drug development in carcinoid tumors (Alliance A021202)

Bergsland, Emily K. , Mahoney, Michelle R. , Asmis, Timothy R. ... - NETRF - - 2019

Abstract - No-Endpoint - Trial-Description-Only - GI - A021202

What Happened to the US Cancer Cooperative Groups? A Status Update Ten Years After the IOM Report

Bertagnolli, Monica M. , Blanke, Charles D. , Curran, Walter J., Jr ... - - Cancer - 2020

Manuscript - No-Endpoint - Other - - No Study Assigned

Demonstrating the value of coincidence analysis for identifying successful implementation strategies

Birken, Sarah A. , Hwang, Soohyun , Viera, Laura , Haines, Emily ... - SIRC - IMPLEMENTATION SCIENCE - 2020

Abstract - No-Endpoint - Trial-Description-Only - CCDR - A23_Pilot2

Challenges for conducting clinical trials evaluating maintenance chemotherapy in acute myeloid leukemia (AML): a Cancer and Leukemia Group B (CALGB) study

Blum, W. , Donohue, K. , Marcucci, G. , Deangelo, D. J. , Uy, G. L. ... - ASH - Blood - 2010

Abstract - No-Endpoint - Comprehensive - Leukemia - CALGB-10503

Impact of the COVID-19 Pandemic on Cancer Clinical Trials

Boughey, Judy C. , Snyder, Rebecca A. , Kantor, Olga , Zheng, Linda ... - - Ann Surg Oncol - 2021

Manuscript - No-Endpoint - Other - OGC funded--no committee - No Study Assigned

Alliance A071701: Genomically guided treatment trial in brain metastases

Brastianos, Priscilla , Anders, Carey , Iafrate, John ... - ASCO - J Clin Oncol - 2020

Abstract - No-Endpoint - Trial-Description-Only - Neuro-Onc - A071701

Development of Clinical Precision Medicine Approaches in Meningiomas: Alliance A071401.

Brastianos, Priscilla , Shi, Qian , Santagata, Sandro ... - SNOM - - 2016

Abstract - No-Endpoint - Trial-Description-Only - Neuro-Onc - A071401

AFT-50 EndoMAP: A phase IB/II multi-cohort study of targeted agents with atezolizumab (Atezo) for patients (pts) with recurrent or persistent endometrial cancer (EC).

Cantillo, Evelyn , Zemla, Tyler , Moroney, John W. ... - IGCS - Internat J Gynecol Cancer - 2022

Abstract - No-Endpoint - Trial-Description-Only - Experimental - AFT-50

Teaching Health-Care Providers to Query Patients With Cancer About Sexual and Gender Minority (SGM) Status and Sexual Health

Cathcart-Rake, Elizabeth J. , Breitkopf, Carmen Radecki ... - - Am J Hosp Palliat Care - 2019

Manuscript - No-Endpoint - Trial-Description-Only - Disparities - Pilot

Querying Cancer Patients About Sexual Health and Sexual and Gender Minority Status: A Qualitative Study of Healthcare Providers

Cathcart-Rake, Elizabeth , O'Connor, Jennifer M. ... - - Am J Hosp Palliat Care - 2020

Manuscript - No-Endpoint - Primary - Disparities - Pilot

Innovative estimation of survival using log-normal survival modelling on ACCENT database

Chapman, J W , O'Callaghan, C J , Hu, N , Ding, K , Yothers, G A ... - - Br J Cancer - 2013

Manuscript - No-Endpoint - Primary - GI - N0441

Methodological Considerations in the Design and Implementation of Clinical Trials

Cirrincione, Constance T. , Lavoie Smith, Ellen M. ... - - Semin Oncol Nurs - 2014

Manuscript - No-Endpoint - Other - Onc Nursing - Pilot

The Breast Cancer Weight Loss (BWEL) Trial (Alliance A011401): A Description and Evidence for the Lifestyle Intervention

Delahanty, Linda M. , Wadden, Thomas A. , Goodwin, Pamela J. ... - - Obesity (Silver Spring) - 2022

Manuscript - No-Endpoint - Trial-Description-Only - Breast - A011401

Hypothetical double-consent design intervention

Demmy, T. L. , Kohman, L. J. ... - CTAS - - 2010

Abstract - No-Endpoint - Primary - Respiratory - CALGB-30102 , CALGB-9334

Features Associated with Successful Recruitment of Diverse Patients onto Cancer Clinical Trials: Report from the American College of Surgeons Oncology Group

Diehl, Kathleen M. , Green, Erin M. , Weinberg, Armin ... - - Ann Surg Oncol - 2011

Manuscript - No-Endpoint - Meta-Analysis - Disparities - Comprehensive

Validity and reliability of the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).

Dueck, A. C. , Mendoza, T. R. , Mitchell, S. A. , Reeve, B. B. ... - ASCO - J Clin Oncol - 2012

Abstract - No-Endpoint - Primary - Health Outcomes - Comprehensive

Attitudes of Clinicians about Screening Head and Neck Cancer Survivors for Lung Cancer Using Low-Dose Computed Tomography

Dukes, Kimberly , Seaman, Aaron T. , Hoffman, Richard M. ... - - Ann Otol Rhinol Laryngol - 2020

Manuscript - No-Endpoint - Primary - Prevention - Pilot

American College of Surgeons Oncology Group Z4099/Radiation Therapy Oncology Group 1021: A randomized study of sublobar resection compared with stereotactic body radiotherapy for high-risk stage I non–small cell lung cancer

Fernando, Hiran C. ... - - J Thorac Cardiovasc Surg - 2012

Manuscript - No-Endpoint - Trial-Description-Only - Respiratory - ACOSOG-Z4099

ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early Stage Non–Small Cell Lung Cancer

Govindan, Ramaswamy , Mandrekar, Sumithra J. , Gerber, David E. ... - - Clin Cancer Res - 2015

Manuscript - No-Endpoint - Trial-Description-Only - Respiratory - A151216

MAIN-CAV: Phase III randomized trial of maintenance cabozantinib (CABO) and avelumab versus Avelumab after first-line platinum-based chemotherapy in patients with metastatic urothelial cancer (mUC) (Alliance A032001).

Gupta, Shilpa , Galsky, Matthew D. , Morris, Michael J. ... - ASCO - J Clin Oncol - 2022

Abstract - No-Endpoint - Trial-Description-Only - GU - A032001

Optimal Two-Stage Dynamic Treatment Regimes from a Classification Perspective with Censored Survival Data

Hager, Rebecca , Tsiatis, Anastasios A. ... - - Biometrics - 2018

Manuscript - No-Endpoint - Other - Leukemia - C9710

N0733: Phase II trial of capecitabine and lapatinib +/- cixutumumab in HER2 positive breast cancer

Haluska, P. , Reinholz, M. M. , Dueck, A. C. , Linden, H. M. ... - ASCO - J Clin Oncol - 2010

Abstract - No-Endpoint - Trial-Description-Only - Breast - N0733

Improving patient-centered communication in breast cancer: a study protocol for a multilevel intervention of a shared treatment deliberation system (SharES) within the NCI community oncology research program (NCORP) (Alliance A231901CD)

Hawley, Sarah T. , Kidwell, Kelley , Zahrieh, David , McCarthy, Anne ... - - Trials - 2023

Manuscript - No-Endpoint - Trial-Description-Only - CCDR - A231901CD

Implementing a multi-level cancer care delivery intervention within the NCI Community Oncology Research Program (NCORP) (Alliance A231901CD)

Hawley, Sarah , Rankin, Aaron , McCarthy, Anne , Wills, Rachel ... - D&I - - 2022

Abstract - No-Endpoint - Other - CCDR - A231901CD

Are we assuming too much with our statistical assumptions? Lessons learned from the ALTTO trial

Holmes, E M , Bradbury, I , Williams, L S , Korde, L , de Azambuja, E ... - - Ann Oncol - 2019

Manuscript - No-Endpoint - Other - Breast - N063D

Public Health and Cooperative Group Partnership: A Colorectal Cancer Educational Intervention for Breast Cancer Survivors

Homan ... - - Semin Oncol Nurs - 2014

Manuscript - No-Endpoint - Other - Onc Nursing - A21_011

A phase II study evaluating the role of sentinel lymph node surgery and axillary lymph node dissection following preoperative chemotherapy in women with node-positive breast cancer (T1-4, N1-2, M0) at initial diagnosis: ACOSOG Z1071

Hunt, K. , Le-Petross, H. T. , Suman, V. , Haffty, B. G. ... - ASCO - J Clin Oncol - 2010

Abstract - No-Endpoint - Trial-Description-Only - Breast - ACOSOG-Z1071

The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)

Hwang, E Shelley , Hyslop, Terry , Lynch, Thomas , Frank, Elizabeth ... - - BMJ Open - 2019

Manuscript - No-Endpoint - Trial-Description-Only - Breast - AFT-25

A Phase II Study of Gemcitabine Plus Cisplatin Chemotherapy in Patients with Muscle-Invasive Bladder Cancer with Bladder Preservation for those Patients whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations (Alliance A031701)

Iyer, Gopa , Ballman, Karla V. , Atherton, Pamela , Murray, Katie ... - ASCO - J Clin Oncol - 2022

Abstract - No-Endpoint - Trial-Description-Only - GU - A031701

The role of patient advocates in clinical trials: Perspectives from investigators and advocates in the Cancer and Leukemia Group B (CALGB)

Katz, M. L. , Archer, L. E. , Peppercorn, J. M. , Kereakoglow, S. ... - ASCO - J Clin Oncol - 2010

Abstract - No-Endpoint - Other - Patient Adv - No Study Assigned

Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas

Katz, Matthew H. G. , Ou, Fang-Shu , Herman, Joseph M. ... - - BMC Cancer - 2017

Manuscript - No-Endpoint - Trial-Description-Only - GI - A021501

Borderline resectable pancreatic cancer: Need for Standardization and Methods for Optimal Clinical Trial Design

Katz, Matthew HG , Marsh, Robert , Herman, Joseph M. , Shi, Qian ... - - Ann Surg Oncol - 2013

Manuscript - No-Endpoint - Comprehensive - GI - A021101

Alliance for clinical trials in oncology trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas

Katz, Matthew , Herman, Joseph M. , Ou, Fang-Shu , Marsh, Robert ... - ASCO - J Clin Oncol - 2017

Abstract - No-Endpoint - Trial-Description-Only - GI - A021501

Nursing contributions in Community Clinical Oncology Research Programs.

Klinger, Kathy , Figueras, Cesar , Beney, Kathleen M , Armer, Jane M ... - - Semin Oncol Nurs - 2014

Manuscript - No-Endpoint - Other - Onc Nursing - No Study Assigned

Nursing's presence in the changing cooperative group setting.

Kottschade, Lisa A , Bell, Jennifer , Klinger, Kathy ... - - Semin Oncol Nurs - 2014

Manuscript - No-Endpoint - Other - Onc Nursing - No Study Assigned

Alliance A151804: Establishment of a national biorepository to advance studies of immune-related adverse events

Kozono, David , Sharon, Elad , Le-Rademacher, Jennifer , Twohy, Erin ... - ASCO - J Clin Oncol - 2020

Abstract - No-Endpoint - Trial-Description-Only - Experimental - A151804 , 9767

Alliance A151804: Establishment of a National Biorepository to Advance Studies of Immune-related Adverse Events

Kozono, David , Zemla, Tyler , Dib, Elie , Watson, Mark , Wen, Yujia ... - SITC - J Immunotherapy Cancer - 2022

Abstract - No-Endpoint - Trial-Description-Only - Immuno-Onc - A151804

Application of multi-state models in cancer clinical trials

Le-Rademacher, Jennifer G , Peterson, Ryan A , Therneau, Terry M ... - - Clin Trials - 2018

Manuscript - No-Endpoint - Other - Leukemia - A151732 , CALGB-10603

Trial Design Considerations to Increase Older Adult Accrual to National Cancer Institute Clinical Trials

Le-Rademacher, Jennifer , Mohile, Supriya , Unger, Joseph ... - - J Natl Cancer Inst Monogr - 2022

Manuscript - No-Endpoint - Other - Older Adult - No Study Assigned

Alliance A051202: A Phase I Trial of Lenalidomide, Rituximab and GS-1101 (Idelalisib) in recurrent follicular lymphoma

Leonard, John P. , Jung, Sin-ho ... - ICML - Hematol Oncol - 2013

Abstract - No-Endpoint - Trial-Description-Only - Lymphoma - A051202

The nurse liaison role in the cooperative group setting.

Levy, Sharon , Klinger, Kathy , Galinsky, Ilene , DeKrey, Wanda ... - - Semin Oncol Nurs - 2014

Manuscript - No-Endpoint - Other - Onc Nursing - No Study Assigned

The Breast Cancer Weight Loss (BWEL) Trial: Randomized Phase III Trial Evaluating The Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer (Alliance A011401)

Ligibel, Jennifer A. , Barry, William T. , Alfano, Catherine ... - ASCO - J Clin Oncol - 2018

Abstract - No-Endpoint - Trial-Description-Only - Breast - A011401

Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design

Ligibel, Jennifer A. , Barry, William T. , Alfano, Catherine ... - - NPJ Breast Cancer - 2017

Manuscript - No-Endpoint - Trial-Description-Only - Breast - A011401

Randomized phase II study comparing the met inhibitor cabozantinib to temozolomide (tmz) or dacarbazine (dtic) in ocular melanoma - A091201

Luke, Jason J. , Allred, Jacob B. , Horvath, Laura E. ... - ASCO - J Clin Oncol - 2015

Abstract - No-Endpoint - Trial-Description-Only - Experimental - A091201

A randomized phase II study of anti-PD-1 antibody [MK-3475 (pembrolizumab)] alone versus anti-PD1 antibody plus stereotactic body radiation therapy in advanced Merkel cell carcinoma (Alliance A091605)

Luke, Jason , Chmura, Steven , Salama, Joseph , Al-Hallaq, Hania ... - ASCO - J Clin Oncol - 2018

Abstract - No-Endpoint - Trial-Description-Only - Experimental - A091605

Comparing an Operation to Monitoring, with or without Endocrine Therapy (COMET): a prospective randomized trial for low-risk DCIS

Lynch, T. , Partridge, A. , Thompson, A. , Frank, E. , Pinto, D. ... - SABCS - Cancer Res - 2020

Abstract - No-Endpoint - Trial-Description-Only - Breast - AFT-25

Alliance A011106: ALTernate approaches for clinical stage II or III Estrogen Receptor positive breast cancer NeoAdjuvant TrEatment (ALTERNATE) in postmenopausal women: A Phase III Study

Ma, Cynthia X. , Suman, Vera , Leitch, A. Marilyn , Sanati, Souzan ... - SABCS - Cancer Res - 2015

Abstract - No-Endpoint - Trial-Description-Only - Breast - A011106

Quality assessment metrics for whole genome gene expression profiling of paraffin embedded samples

Mahoney, D. W. , Therneau, T. M. , Anderson, S. K. , Jen, J. ... - - BMC Res Notes - 2013

Manuscript - No-Endpoint - Primary - PPP - N9831

Combining Survival and Toxicity Effect Sizes from Clinical Trials: NCCTG 89-20-52 (Alliance)

Major-Elechi, Brittny T. , Novotny, Paul J. , Singh, Jasvinder A. ... - - Int J Stat Med Res - 2018

Manuscript - No-Endpoint - Other - Health Outcomes - NCCTG-89-20-52

Phase 2 Randomized Trial of Neoadjuvant or Palliative Chemotherapy with or without Immunotherapy for Peritoneal Mesothelioma (Alliance: A092001)

Mansfield, Aaron , Goodrich, Austin , Foster, Nathan ... - ASCO - J Clin Oncol - 2022

Abstract - No-Endpoint - Trial-Description-Only - Experimental - A092001

CHIO3: Chemotherapy combined with immune checkpoint inhibitor for operable stage IIIA/B non-small cell lung cancer (AFT-46)

Martin, Linda W. , Wang, Xiaofei , Patel, Jyoti D. , Kozono, David ... - IASLC (WCLC) - J Thorac Oncol - 2021

Abstract - No-Endpoint - Trial-Description-Only - Respiratory - AFT-46

How Much Missing Data is Too Much? Monte Carlo Simulations to Develop SISAQOL Guidelines for Missing Data Handling.

Mazza, Gina L. , Coens, Corneel , Pe, Madeline , Dorme, Lien ... - ISOQOL - Qual Life Res - 2018

Abstract - No-Endpoint - Other - Health Outcomes - N07C2

A randomized trial of radium-223 (Ra-223) dichloride and cabozantinib in patients (pts) with advanced renal cell carcinoma (RCC) with bone metastases (RADICAL / Alliance A031801)

McKay, Rana R. , Atherton, Pamela , Jacene, Heather ... - KCRS - - 2022

Abstract - No-Endpoint - Trial-Description-Only - GU - A031801

A randomized trial of radium-223 dichloride and cabozantinib in patients with advanced renal cell carcinoma (RCC) with bone metastases (RADICAL / Alliance A031801)

McKay, Rana R. , Jacene, Heather , Atherton, Pamela ... - ASCO - J Clin Oncol - 2021

Abstract - No-Endpoint - Trial-Description-Only - GU - A031801

Alliance A059102: A Randomized Phase II US Intergroup Study of CHO(E)P vs CC-486-CHO(E)P vs DUVELISIB-CHO(E)P in Previously Untreated CD30 Negative Peripheral T-Cell Lymphomas

Mehta-Shah, Neha , Geyer, Susan , Bartlett, Nancy , Barta, Stefan ... - IUCLS - - 2022

Abstract - No-Endpoint - Trial-Description-Only - Lymphoma - A051902

Alliance A059102: A Randomized Phase II US Intergroup Study of CHO(E)P vs CC-486-CHO(E)P vs DUVELISIB-CHO(E)P in Previously Untreated CD30 Negative Peripheral T-Cell Lymphomas

Mehta-Shah, Neha , Geyer, Susan , Bartlett, Nancy , Barta, Stefan ... - ASCO - J Clin Oncol - 2022

Abstract - No-Endpoint - Trial-Description-Only - Lymphoma - A051902

Adjuvant study of amcenestrant (SAR439859) versus tamoxifen for patients with hormone receptor-positive (HR+) early breast cancer (EBC), who have discontinued adjuvant aromatase inhibitor therapy due to treatment-related toxicity (AMEERA-6).

Meyskens, Thomas , Metzger, Otto , Poncet, Coralie ... - ASCO - J Clin Oncol - 2022

Abstract - No-Endpoint - Trial-Description-Only - Breast - AFT-55

Central review of cytogenetics is necessary for cooperative group correlative and clinical studies of adult acute leukemia: The Cancer and Leukemia Group B experience

Mrózek, Krzysztof , Carroll, Andrew J. , Maharry, Kati ... - - Int J Oncol - 2008

Manuscript - No-Endpoint - Comprehensive - Leuk Corr Sci - CALGB-8461

Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?

Mrózek, Krzysztof , Marcucci, Guido , Paschka, Peter ... - - Blood - 2007

Manuscript - No-Endpoint - Other - Leuk Corr Sci - No Study Assigned

Trial In Progress: A Phase II Study of Lenalidomide, Ixazomib, Dexamethasone, and Daratumumab in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (AFT-41).

O'Donnell, Elizabeth , Suman, Vera , Geyer, Susan , Nadeem, Omar ... - ASH - Blood - 2021

Abstract - No-Endpoint - Trial-Description-Only - Myeloma - AFT-41

Alliance A011801 (compassHER2 RD): postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer (NCT04457596)

O'Sullivan, Ciara C. , Ballman, Karla V. , McCall, Linda ... - ASCO - J Clin Oncol - 2021

Abstract - No-Endpoint - Trial-Description-Only - Breast - A011801

Alliance A011801 (compassHER2 RD): postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer

O'Sullivan, Ciara C , Ballman, Karla V , McCall, Linda ... - - Future Oncol - 2021

Manuscript - No-Endpoint - Trial-Description-Only - Breast - A011801

Milestone prediction for time-to-event endpoint monitoring in clinical trials

Ou, Fang-Shu , Heller, Martin ... - - Pharm Stat - 2019

Manuscript - No-Endpoint - Other - GI - A151730

Adjuvant targeted therapy following standard adjuvant therapy for resected NSCLC: An initial report from ALCHEMIST (Alliance A151216)

Oxnard, Geoffrey R. , Mandrekar, Sumithra , Hillman, Shauna ... - IASLC (WCLC) - J Thorac Oncol - 2018

Abstract - No-Endpoint - Preliminary - Respiratory - A151216

The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: a study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD

Pacyna, Joel E. , Kim, Simon , Yost, Kathleen , Sedlacek, Hillary ... - - BMC Cancer - 2018

Manuscript - No-Endpoint - Trial-Description-Only - CCDR - A191402CD

Lessons learned from implementing the first Alliance NCORP Research Base Cancer Care Delivery Research (CCDR) trial A191402CD

Pacyna, Joel E. , Sloan, Jeff , Kim, Simon , Sedlacek, Hillary ... - ASCO QCS - J Clin Oncol - 2018

Abstract - No-Endpoint - Other - Disparities - A191402CD

Lessons learned from conducting the first cancer care delivery trial in the Alliance for Clinical Trials in Oncology (Alliance A191402CD).

Pacyna, Joel E , Dueck, Amylou C , Chang, George J , Chow, Selina ... - - Clin Trials - 2023

Manuscript - No-Endpoint - Other - CCDR - A191402CD

Prognostic Model for Mesothelioma Based on Cancer and Leukemia Group B (CALGB) Trials (Alliance)

Pang, Herbert , Yan, Kang , Kratzke, Robert , Stinchcombe, Thomas ... - IASLC (WCLC) - J Thorac Oncol - 2017

Abstract - No-Endpoint - Meta-Analysis - Respiratory - CALGB-30101 , CALGB-30107 , CALGB-30307 , CALGB-30601 , CALGB-39807 , CALGB-8435 , CALGB-8638 , CALGB-8833 , CALGB-8933 , CALGB-9031 , CALGB-9131 , CALGB-9234 , CALGB-9530 , CALGB-9631 , CALGB-9733

A Randomized Trial of Diet in Men with Early Stage Prostate Cancer on Active Surveillance: Rationale and Design of the Men’s Eating and Living (MEAL) Study (CALGB 70807 [Alliance])

Parsons, J. Kellogg , Pierce, John P. , Mohler, James ... - - Contemp Clin Trials - 2014

Manuscript - No-Endpoint - Trial-Description-Only - Prevention - CALGB-70807

Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy☆

Partridge, Ann H. , Niman, Samuel M. , Ruggeri, Monica ... - - Breast - 2021

Manuscript - No-Endpoint - Other - Symptom Inter - A221405

Baseline Characteristics of Women Enrolled in the POSITIVE Trial (Pregnancy Outcome and Safety of Interrupting Therapy for women with endocrine responsIVE breast cancer)

Partridge, Ann H , Niman, Samuel M , Ruggeri, Monica ... - SABCS - Cancer Res - 2021

Abstract - No-Endpoint - Other - Symptom Inter - A221405 , IBSCG 48-14

Improving standards of patient reported outcomes analysis: developing a consensus taxonomy of key research objectives – a SISAQOL initiative

Pe, Madeline , Dorme, Lien , Coens, Corneel , Basch, Ethan ... - ISOQOL - Qual Life Res - 2018

Abstract - No-Endpoint - Other - Health Outcomes - No Study Assigned

Ethics of Mandatory Research Biopsy for Correlative End Points Within Clinical Trials in Oncology

Peppercorn, Jeffrey , Shapira, Iuliana , Collyar, Deborah ... - - J Clin Oncol - 2010

Manuscript - No-Endpoint - Comprehensive - Ethics - No Study Assigned

Tobacco Assessment in Completed Lung Cancer Treatment Trials

Peters, Erica N. , Warren, Graham W. , Sloan, Jeff A. ... - - Cancer - 2016

Manuscript - No-Endpoint - Meta-Analysis - Prevention - Comprehensive

Highly efficient clinical trial designs for reliable screening of under-performing treatments: Application to the COVID-19 Pandemic.

Piantadosi ... - - Clin Trials - 2020

Manuscript - No-Endpoint - Other - SDMC NOS - No Study Assigned

Alliance A031902 (CASPAR): A randomized, phase 3 trial of enzalutamide (ENZ) with rucaparib (RUCA)/placebo (PBO) in first-line metastatic castration-resistant prostate cancer (mCRPC)

Rao, Arpit , Heller, Glenn , Ryan, Charles J. ... - ASCO GU - J Clin Oncol - 2023

Abstract - No-Endpoint - Trial-Description-Only - GU - A031902

Alliance A031902 (CASPAR): A randomized, phase III trial of enzalutamide (ENZ) with rucaparib (RUCA)/placebo (PBO) as novel therapy in first-line metastatic castration-resistant prostate cancer (mCRPC).

Rao, Arpit , Heller, Glenn , Ryan, Charles J. ... - ASCO GU - J Clin Oncol - 2022

Abstract - No-Endpoint - Trial-Description-Only - GU - A031902

CASPAR (Alliance A031902) - A Randomized, Phase III Trial of Enzalutamide with/without Rucaparib as a Novel Therapy in First-Line Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Rao, Arpit , Ryan, Charles J , Vanderweele, David , Heller, Glenn ... - ASCO GU - J Clin Oncol - 2021

Abstract - No-Endpoint - Trial-Description-Only - GU - A031902

CASPAR (Alliance A031902) - A Randomized, Phase III Trial of Enzalutamide with/without Rucaparib as a Novel Therapy in First-Line Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Rao, Arpit , Ryan, Charles J , Vanderweele, David , Heller, Glenn ... - ASCO - J Clin Oncol - 2022

Abstract - No-Endpoint - Trial-Description-Only - GU - A031902

Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: Design of the TEXT and SOFT trials

Regan, Meredith M. , Pagani, Olivia , Fleming, Gini F. ... - - Breast - 2013

Manuscript - No-Endpoint - Trial-Description-Only - Breast - IBCSG-24-02 (SOFT-TEXT)

Cancer and Leukemia Group B Pathology Committee Guidelines for Tissue Microarray Construction Representing Multicenter Prospective Clinical Trial Tissues

Rimm, David L. , Nielsen, Torsten O. , Jewell, Scott D. ... - - J Clin Oncol - 2011

Manuscript - No-Endpoint - Comprehensive - Pathology - C9741 , CALGB-9840

ASO Author Reflections: Multiple Ipsilateral Breast Cancer: Where Have We Been, Where are We Going.

Rosenkranz, Kari M ... - - Ann Surg Oncol - 2020

Manuscript - No-Endpoint - Other - Breast - No Study Assigned

Phase II Trial of Atezolizumab Before and After Definitive Chemoradiation for Patients with Unresectable Stage III NSCLC

Ross, Helen J. , Kozono, David , Urbanic, James , Williams, Terence ... - IASLC (WCLC) - J Thorac Oncol - 2017

Abstract - No-Endpoint - Trial-Description-Only - Respiratory - AFT-16

Application of a sequential multiple assignment randomized trial (SMART) design in older patients with chronic lymphocytic leukemia

Ruppert, A S , Yin, J , Davidian, M , Tsiatis, A A , Byrd, J C ... - - Ann Oncol - 2019

Manuscript - No-Endpoint - Other - Leukemia - A041202

Integration of immunotherapy into adjuvant therapy for resected non-small-cell lung cancer: ALCHEMIST chemo-IO (ACCIO)

Sands, Jacob M , Mandrekar, Sumithra J , Kozono, David ... - - Immunotherapy - 2021

Manuscript - No-Endpoint - Trial-Description-Only - Respiratory - A081801

ALCHEMIST: Adjuvant targeted therapy or immunotherapy for high risk resected NSCLC (Alliance)

Sands, Jacob , Oxnard, Geoffrey R. , Kozono, David ... - ASCO - J Clin Oncol - 2020

Abstract - No-Endpoint - Trial-Description-Only - Respiratory - A081105 , A151216 , A081801

End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group.

Sargent, Daniel J , Patiyil, Smitha , Yothers, Greg ... - - J Clin Oncol - 2007

Manuscript - No-Endpoint - Other - GI - ACCENT

Daratumumab (DARA) + Lenalidomide, Bortezomib, and Dexamethasone (RVd) in Patients (Pts) With Transplant-eligible Newly Diagnosed Multiple MyNewly diagnosed multiple myeloma, daratumumab, autologous stem cell transplanteloma (NDMM): Final Analysis of GRIFFIN

Sborov, Douglas W. , Laubach, Jacob , Kaufman, Jonathan L. ... - IMS - - 2022

Abstract - No-Endpoint - Other - Myeloma - AFT-29 (GRIFFIN)

Alliance A082002 SBRT for PD-l1-negative, advanced non-small cell lung cancer

Schild, Steven E. , Wang, Xiaofei , Bestvina, Christine M. ... - - Clin Lung Cancer - 2022

Manuscript - No-Endpoint - Trial-Description-Only - Respiratory - A082002

Increasing socioeconomically disadvantaged patients’ engagement in breast cancer surgery decision-making through a shared decision-making intervention (A231701CD): protocol for a cluster randomised clinical trial

Schumacher, Jessica R , Zahrieh, David , Chow, Selina , Taylor, John ... - - BMJ Open - 2022

Manuscript - No-Endpoint - Trial-Description-Only - CCDR - A231701CD

Normative data and clinically significant effect sizes for single-item numerical linear analogue self-assessment (LASA) scales

Singh, Jasvinder A , Satele, Daniel , Pattabasavaiah, Suneetha ... - - Health Qual Life Outcomes - 2014

Manuscript - No-Endpoint - Meta-Analysis - Health Outcomes - 954651 , NCCTG-95-20-53 , NCCTG-95-24-52 , 959204 , NCCTG-964251 , 979202 , NCCTG-97-24-51 , NCCTG-98-24-52 , NCCTG-959257 , NCCTG-98-72-51 , NCCTG-98-72-52 , NCCTG-989251 , NCCTG-969256 , NCCTG-971151 , NCCTG-979251 , NCCTG-979253

Randomized Trial of FOLFOX Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair or Microsatellite Instability (ATOMIC, Alliance A021502)

Sinicrope, FA , Ou, F-S , Shi, Q , Nixon, A , Mody, Kabir ... - ASCO - J Clin Oncol - 2017

Abstract - No-Endpoint - Trial-Description-Only - GI - A021502

Lessons from Large Scale Collection of Patient Reported Outcomes: Implications for Big Data Aggregation and Analytics

Sloan, Jeff A. , Halyard, Michele , El Naqa, Issam ... - - Int J Radiat Oncol Biol Phys - 2016

Manuscript - No-Endpoint - Other - Health Outcomes - N9741 , NCCTG-89-20-52

Development of a Personalized mHealth Program for Cancer Symptom and Complication Management.

Song, Lixin , Idiagbonya, Eno , Su, Kevin ... - - Stud Health Technol Inform - 2020

Manuscript - No-Endpoint - Trial-Description-Only - Symptom Inter - NCT04492007

Episodic future thinking: A behavioral intervention to promote weight loss in breast cancer survivors.

Sukumar, Jasmine S , Vaughn, Jennifer , Stein, Jeffrey ... - ASCO - J Clin Oncol - 2022

Abstract - No-Endpoint - Trial-Description-Only - Prevention - A21_Pilot10

The ALTERNATE trial: assessing a biomarker driven strategy for the treatment of post-menopausal women with ER+/Her2− invasive breast cancer

Suman, Vera Jean , Ellis, Matthew J. ... - - Chin Clin Oncol - 2015

Manuscript - No-Endpoint - Trial-Description-Only - Breast - A011106

A phase I/randomized phase II study of MLN0128 vs. Pazopanib in patients with locally advanced/unresectable and/or metastatic sarcoma: Alliance A091304

Tap, William , Mahoney, Michelle , Horvath, Elise ... - ASCO - J Clin Oncol - 2016

Abstract - No-Endpoint - Trial-Description-Only - Experimental - A091304

Alliance A041701 - A randomized phase 2/3 study of conventional chemotherapy +/- uproleselan (GMI-1271) in older adults with acute myeloid leukemia receiving intensive induction chemotherapy

Uy, Geoffrey L. , Yin, Vivien , Klepin, Heidi , Dinner, Shira ... - ASH - Blood - 2019

Abstract - No-Endpoint - Trial-Description-Only - Leukemia - A041701

A randomized phase II trial of vitamin D vs placebo in premenopausal women: CALGB 70806

Wood, M. E. , Kinglsey, F. , Ambaye, A. B. , Yee, L. , Jung, S. J. ... - AACR - Cancer Res - 2011

Abstract - No-Endpoint - Trial-Description-Only - Prevention - CALGB-70806

Change in mammographic density with metformin use: A companion study to NCIC study MA.32.

Wood, Marie E. , Qin, Rui , Le-Petross, Huong T. , Hwang, E Shelley ... - ASCO - J Clin Oncol - 2013

Abstract - No-Endpoint - Trial-Description-Only - Breast - A211201

Objective Measures of Performance Status in Cancer: A pilot Alliance study

Wood, WA , Tan, X , Grover, NS , Stover, A , Kannappan, A ... - ASCO QCS - J Clin Oncol - 2018

Abstract - No-Endpoint - Primary - Disparities - Pilot

Pathways: patient-centred decision counselling for women at risk of cancer-related infertility: a protocol for a comparative effectiveness cluster randomised trial

Woodard, Terri Lynn , Hoffman, Aubri S , Crocker, Laura C ... - - BMJ Open - 2018

Manuscript - No-Endpoint - Trial-Description-Only - CCDR - NCT03141437

Alliance A041702: A randomized phase III study of ibrutinib plus obinutuzumab versus ibrutinib plus venetoclax and obinutuzumab in untreated older patients (≥ 70 years of age) with chronic lymphocytic leukemia (CLL)

Woyach, Jennifer A. , Ruppert, Amy S. , Perez, Gabriela ... - ASH - Blood - 2019

Abstract - No-Endpoint - Trial-Description-Only - Leukemia - A041702

Alliance A041702: A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (≥ 70 Years of Age) with Chronic Lymphocytic Leukemia (CLL)

Woyach, Jennifer A. , Ruppert, Amy S. , Perez, Gabriela ... - ASH - Blood - 2021

Abstract - No-Endpoint - Trial-Description-Only - Leukemia - A041702

Successes and lessons learned in database development for national multi-site cancer care delivery research trials: the Alliance for Clinical Trials in Oncology experience

Zahrieh, David , Hillman, Shauna L. , Tan, Angelina D. ... - - Trials - 2022

Manuscript - No-Endpoint - Primary - SDMC NOS - A191402CD , A231601CD , A231602CD , A231701CD , A231901CD

PDIGREE: An adaptive phase 3 trial of PD-inhibitor nivolumab and Ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated REnal Cell CancEr (Alliance A031704)

Zhang, Tian , Ballman, Karla , Choudhury, Atish , Chen, Ronald C. ... - ASCO GU - J Clin Oncol - 2021

Abstract - No-Endpoint - Trial-Description-Only - GU - A031704

PDIGREE: An adaptive phase 3 trial of PD-inhibitor nivolumab and Ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated REnal Cell CancEr (Alliance A031704)

Zhang, Tian , Ballman, Karla , Choudhury, Atish , Chen, Ronald C. ... - ASCO - J Clin Oncol - 2020

Abstract - No-Endpoint - Trial-Description-Only - GU - A031704

PDIGREE: An adaptive phase 3 trial of PD-inhibitor nivolumab and Ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated REnal Cell CancEr (Alliance A031704)

Zhang, Tian , Ballman, Karla , Choudhury, Atish , Chen, Ronald C. ... - IKCS - J Clin Oncol - 2020

Abstract - No-Endpoint - Trial-Description-Only - GU - A031704

PDIGREE: An adaptive phase 3 trial of PD-inhibitor nivolumab and Ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated REnal Cell CancEr (Alliance A031704)

Zhang, Tian , Ballman, Karla , Choudhury, Atish , Chen, Ronald C. ... - ASCO - J Clin Oncol - 2019

Abstract - No-Endpoint - Trial-Description-Only - GU - A031704